Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG 2nd, Buckner JC, James CD, Aldape K. Pelloski CE, et al. Among authors: colman h. J Clin Oncol. 2007 Jun 1;25(16):2288-94. doi: 10.1200/JCO.2006.08.0705. J Clin Oncol. 2007. PMID: 17538175
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K. McDonald JM, et al. Among authors: colman h. Cancer. 2005 Oct 1;104(7):1468-77. doi: 10.1002/cncr.21338. Cancer. 2005. PMID: 16088966 Free article.
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK; Radiation Therapy Oncology Group. Colman H, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):818-24. doi: 10.1016/j.ijrobp.2006.05.021. Epub 2006 Aug 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16887285 Clinical Trial.
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.
Puduvalli VK, Giglio P, Groves MD, Hess KR, Gilbert MR, Mahankali S, Jackson EF, Levin VA, Conrad CA, Hsu SH, Colman H, de Groot JF, Ritterhouse MG, Ictech SE, Yung WK. Puduvalli VK, et al. Among authors: colman h. Neuro Oncol. 2008 Apr;10(2):216-22. doi: 10.1215/15228517-2007-060. Epub 2008 Feb 26. Neuro Oncol. 2008. PMID: 18314417 Free PMC article. Clinical Trial.
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S, Wefel JS, Gilbert MR, Ictech S, Hunter KU, Forman AD, Puduvalli VK, Colman H, Hess KR, Yung WK. Groves MD, et al. Among authors: colman h. Neuro Oncol. 2008 Apr;10(2):208-15. doi: 10.1215/15228517-2007-059. Epub 2008 Mar 3. Neuro Oncol. 2008. PMID: 18316473 Free PMC article. Clinical Trial.
Brain tumor stem cells.
Sulman E, Aldape K, Colman H. Sulman E, et al. Among authors: colman h. Curr Probl Cancer. 2008 May-Jun;32(3):124-42. doi: 10.1016/j.currproblcancer.2008.02.004. Curr Probl Cancer. 2008. PMID: 18501775 Review. No abstract available.
203 results